CHC
ALXN

City Holding Co’s Alexion Pharmaceuticals ALXN Stock Holding History

City Holding Co’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-38
Closed -$5K – 518
2019
Q1 		$5K Hold
38
– – ﹤0.01% 429
2018
Q4 		$4K Hold
38
– – ﹤0.01% 433
2018
Q3 		$5K Hold
38
– – ﹤0.01% 452
2018
Q2 		$5K Hold
38
– – ﹤0.01% 452
2018
Q1 		$4K Hold
38
– – ﹤0.01% 489
2017
Q4 		$5K Hold
38
– – ﹤0.01% 476
2017
Q3 		$5K Hold
38
– – ﹤0.01% 470
2017
Q2 		$5K Hold
38
– – ﹤0.01% 474
2017
Q1 		$5K Hold
38
– – ﹤0.01% 469
2016
Q4 		$5K Hold
38
– – ﹤0.01% 448
2016
Q3 		$5K Hold
38
– – ﹤0.01% 439
2016
Q2 		$4K Buy
+38
New +$5.39K ﹤0.01% 475

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return